Smart scale for swelling: could a Foot-Volume monitor keep heart patients out of hospital?

NCT ID NCT06222099

First seen Jun 24, 2026 · Last updated Jul 29, 2026 · Updated 7 times

Summary

This study tests a device that automatically measures foot swelling in people with chronic heart failure. The device sends alerts to healthcare teams if swelling increases, which could signal worsening heart failure. About 1,500 participants will use the device at home for at least a year, and researchers will compare hospital visits and data availability to standard care. The goal is to see if this passive monitoring reduces hospitalizations and improves patient management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Heartfelt device (a remote monitoring device that measures foot volume to detect swelling)
What this could lead to
If successful, this device could help heart failure patients avoid hospital stays by catching fluid buildup early.
What could go wrong
This is a pragmatic trial with no blinding, so results may be influenced by patient or staff awareness. The device is not a treatment, only a monitoring tool, and its impact on hospitalizations may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Baptist Health

    ACTIVE_NOT_RECRUITING

    Little Rock, Arkansas, 72205, United States

  • Connect America

    RECRUITING

    Bala-Cynwyd, Pennsylvania, 19004, United States

  • HealthArc

    RECRUITING

    Hackensack, New Jersey, 07601, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.